ArticleTechnology in cancer research & treatment

Avoidance and Period-Shortening of Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer in Stages I and II: Importance of Ki-67 Labeling Index and the Recognition of Apocrine-Type Lesions.

Koichi Kubouchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.